🇺🇸 FDA
Patent

US 9636301

In vitro release assay for liposome encapsulated vincristine

granted A61KA61K31/439A61K9/1275

Quick answer

US patent 9636301 (In vitro release assay for liposome encapsulated vincristine) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/439, A61K9/1275